Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...

Intratracheal administration of budesonide mixed with surfactant did not reduce the rates of bronchopulmonary dysplasia (BPD) or death compared with surfactant alone in extremely premature infants by ...

Researchers conducted a meta-analysis of 12 randomized controlled trials involving 2428 premature infants, comparing intratracheal budesonide plus pulmonary surfactant with pulmonary surfactant alone.